Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004867 · ClinicalTrials.gov registry record · NA
Positron Emission Tomography in Determining Stage of Esophageal Cancer
A NA study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- NA
- Development phase
- 235
- Enrollment target
NCT00004867: Completed NA study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00004867 is a NA study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 235 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004867, a NA study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
Study Summary
RATIONALE: Imaging procedures such as positron emission tomography may improve the ability to determine the stage of esophageal cancer. PURPOSE: This clinical trial is studying how well fludeoxyglucose F 18 positron emission tomography determines tumor stage in patients with esophageal cancer.
Interventions
- RADIATION fludeoxyglucose F 18
- PROCEDURE positron emission tomography
- PROCEDURE conventional surgery
- PROCEDURE radionuclide imaging
- DRUG chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 1999-11 |
| Est. Completion | 2009-01 |
| Phase | NA |
What the finished NCT00004867 record still lists
NCT00004867 is an interventional study that assigns participants to a tested intervention. The registered 235 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 5 interventions - of which fludeoxyglucose F 18 is the first listed.
NCT00004867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004867 about?
NCT00004867 is a clinical study titled "Positron Emission Tomography in Determining Stage of Esophageal Cancer". RATIONALE: Imaging procedures such as positron emission tomography may improve the ability to determine the stage of esophageal cancer. PURPOSE: This clinical trial is studying how well fludeoxyglucose F 18 positron emission tomography determines tumor stage in patients with esophageal cancer.
What is the current status of trial NCT00004867?
This trial is currently completed. It is a NA study. The enrollment target is 235 participants. The study started on 1999-11. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00004867?
The interventions under investigation include: fludeoxyglucose F 18 (RADIATION), positron emission tomography (PROCEDURE), conventional surgery (PROCEDURE), radionuclide imaging (PROCEDURE), chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00004867?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00004867's enrollment target sits among peer trials
235 461st of 2000 higher than 1,539 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01524211 · 235 participants · NA
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
- NCT05316155 · 235 participants · Phase 1
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
- NCT05353569 · 235 participants · NA
Coherent Optical Detection of Middle Ear Disease
- NCT05390918 · 235 participants · NA
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia